You are here: Industry Insights > cancer

News List

Many Lung Cancer Patients Receive Meds That Prolong QTc Interval drugs
December 17, 2019
A considerable proportion of patients with lung cancer are prescribed medications that prolong the corrected QT (QTc) interval ...
Free tool simplifies cancer research worldpharmanews
December 17, 2019
Every cell contains a vast number of proteins, each of which has a specific function, for example as a receptor for another molecule or an enzyme that catalyses chemical reactions.
Biomedical engineers develop system that allows for real-time observations of individual cells in colon Expresspharma
December 16, 2019
Researchers expect the procedure to allow new investigations into the digestive system’s microbiome as well as the causes of diseases like...
For Some, Follicular Lymphoma May Be Curable drugs
December 12, 2019
Some patients in remission from the blood?cancer?called?follicular lymphoma?can be considered cured, a new small study suggests.
Sanofi to acquire Synthorx for $2.5 B biospectrumasia
December 12, 2019
Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders.
Insurance Disparities ID'd in Diagnosis of Late-Stage Melanoma drugs
December 12, 2019
For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with ...
Microcapsules provide targeted chemotherapy drug delivery to cancer cells europeanpharmaceuticalreview
December 12, 2019
Development of infrared light-sensitive microcapsules could be the future in targeted drug delivery for cancer treatment, says new research.
Merck to Acquire ArQule for $2.7B ContractPharma
December 11, 2019
Diversifies oncology pipeline with expansion into targeted therapies that treat hematological malignancies.
Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaboration to Develop New Cancer Treatments biopharmadive
December 10, 2019
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company...
ImCheck raises Series B funds to develop gamma delta therapies pharmaceutical-technology
December 09, 2019
French biotech firm ImCheck Therapeutics has raised $53m (€48m) in a Series B funding round to develop its gamma delta (γδ) T-cell-based antibodies to treat cancer and autoimmune disorders.